#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiac failure acute General anaesthesia Metastatic malignant melanoma Anaplastic thyroid cancer Small intestine neuroendocrine tumour Langerhans' cell histiocytosis Retinopathy of prematurity Osteosarcoma metastatic Uveal melanoma Human papilloma virus immunisation Microscopic polyangiitis Exudative retinopathy Myxofibrosarcoma Hormone-dependent prostate cancer Lymphoma More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis – Basic Information Metachromatic leukodystrophy Myxofibrosarcoma – Life with Disease Paroxysmal nocturnal haemoglobinuria Cystic fibrosis – Trials in Disease Myelodysplastic syndrome with excess blasts – Trials in Disease Systemic mastocytosis – Treatment Gaucher’s disease type III – Treatment KBG syndrome – Diagnostics Rhabdomyosarcoma recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Siremadlin GSKVX000000034794 Lorlatinib Anhydrous Benzoyl Peroxide Tazobactam Carbamazepine Sitagliptin Bdc-1001 Alectinib Triamcinolone Orlistat RO7288817 Taldefgrobep Alfa Ponsegromab Zoledronic Acid Monohydrate Lurasidone Varenicline Auto4 FLUCLOXACILLIN SODIUM Plasma More therapies…

    Learn about Your Condition

    Partial lipodystrophy Ischaemic skin ulcer Herpes simplex Hepatobiliary cancer Bone marrow failure Juvenile psoriatic arthritis Systemic lupus erythematosus Dry mouth Nephropathy PIK3CA-activated mutation Chronic hepatitis B Bipolar I disorder Anal squamous cell carcinoma Vulvovaginal discomfort Desmoplastic melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Topical Chloramphenicol vs Topical Ciprofloxacin for Treating Otorrhea in Adults with Chronic Suppurative Otitis Media

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ciprofloxacin
    Spain

  • Effect of High‑Dose Thiamine Hydrochloride on Fatigue in Rheumatoid Arthritis Patients: Randomized, Double‑Blind, Placebo‑Controlled Trial

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Thiamine Hydrochloride
    Denmark

  • Phase 2 Study of Durvalumab + Tremelimumab with Lenvatinib vs Durvalumab + Tremelimumab Alone in Patients with Unresectable Hepatocellular Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Tremelimumab
    • Durvalumab
    • Lenvatinib
    Italy

  • Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Colitis
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    Belgium Germany Hungary Italy Poland

  • Study of mirikizumab versus azathioprine in newly diagnosed moderate-to-severe Crohn’s disease patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Azathioprine
    • Mirikizumab
    Germany

  • Randomized phase III adjuvant capecitabine plus temozolomide versus surveillance in patients with resected stage I‑III pancreatic neuroendocrine tumors

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic neuroendocrine tumour
    Investigated Drugs:
    • Temozolomide
    • Capecitabine
    France
Previous Page
1 … 695 696 697 698 699 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!